An aciclovir intermediate can prevent drug-induced acute kidney injury
Open Access
- 7 November 2025
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 216, 107367
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Barbour Foundation
- Kidney Research UK
- Engineering and Physical Sciences Research Council (EP/Y014596/1)
This publication has 32 references indexed in Scilit:
- Meta-analysis guided development of a standard artificial urineEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Molecular Imposters Functioning as Versatile Growth Modifiers of Urate CrystallizationCrystal Growth & Design, 2023
- Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in UrineJournal of Urology, 2015
- Acute kidney injury: an increasing global concernThe Lancet, 2013
- Mechanisms of Stone FormationClinical & Translational Metabolism, 2011
- Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exerciseMetabolism, 2006
- HABIT95 — a program for predicting the morphology of molecular crystals as a function of the growth environmentJournal of Crystal Growth, 1996
- Pharmacokinetics of acyclovir in humans following intravenous administrationThe American Journal of Medicine, 1982
- Radionuclide Cystography: The Significance of Retention Time of the Refluxed RadioisotopeJournal of Urology, 1981
- CrystalluriaJournal of Crystal Growth, 1981